Chemotherapy
Approved for: NSCLC
Pemetrexed (Pemfxy/Alimta) is a FDA-approved treatment for nonsquamous non-small cell lung cancer in certain patients whose disease is recurrent, locally advanced or has metastasized (spread to other parts of the body).
